Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

MEDIFAST INC Common Stock (NY:MED)

12.91 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, May 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about MEDIFAST INC Common Stock

Medifast Announces First Quarter 2025 Financial Results
From Medifast
Via Business Wire
Medifast to Announce Financial Results for the First Quarter Ended March 31, 2025
From Medifast
Via Business Wire
Medifast Announces Fourth Quarter and Full Year 2024 Financial Results
From Medifast
Via Business Wire
Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2024
From Medifast
Via Business Wire
Medifast Introduces New High-Protein Product Line OPTAVIA ASCEND™ For GLP-1 Users & Those Looking for Help to Keep Weight Off
From Medifast
Via Business Wire
Medifast Survey Finds Majority of U.S. Adults Trying to Lose Weight Agree Lifestyle Changes Are Essential – Even with Weight Loss Medications
From Medifast
Via Business Wire
Medifast Announces Third Quarter 2024 Financial Results
From Medifast
Via Business Wire
Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2024
From Medifast
Via Business Wire
Medifast Announces Second Quarter 2024 Financial Results
From Medifast
Via Business Wire
Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2024
From Medifast, Inc.
Via Business Wire
Medifast Named as One of The “Best Companies To Work For” by U.S. News & World Report
From Medifast
Via Business Wire
LifeMD Can Surge on Its GLP-1 Offerings
LifeMD is a leading telehealth provider that investors should take note of; the company is entering the GLP-1 market, and its stock could soar as a result 
Via MarketBeat
Medifast Continues Business Transformation, Launching National Marketing Campaign Promoting its Holistic Offering for Customers Utilizing and Considering Weight Loss Medications
From Medifast
Via Business Wire
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Medifast, Inc. and Encourages Investors to Contact the Firm
From Schall Law
Via GlobeNewswire
Medifast Announces First Quarter 2024 Financial Results
From Medifast, Inc.
Via Business Wire
Medifast to Announce Financial Results for the First Quarter Ended March 31, 2024
From Medifast
Via Business Wire
LifeMD Shares Come Back to Life on GLP-1 Business Growth
LifeMD stock is surging as the company is riding the GLP-1 trend to double-digit revenue growth and projections for 67% earnings growth in 2024 
Via MarketBeat
Medifast Announces Fourth Quarter and Full Year 2023 Financial Results
From Medifast
Via Business Wire
Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2023
From Medifast
Via Business Wire
Medifast Announces Third Quarter 2023 Financial Results
From Medifast
Via Business Wire
Medifast Initiates Business Transformation by Entering the Medically Supported Weight Loss Market through Collaboration with LifeMD, a Virtual Primary Care Provider, and Adjusting its Capital Allocation Policy
From Medifast
Via Business Wire
Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2023
From Medifast
Via Business Wire
Institutions Are Buying Under Appreciated Consumer Staples Now
Institutions are buying undervalued consumer staples with solid cash flow, dividends, and healthy balance sheets like Medifast. 
Via MarketBeat
Are These Consumer Staples Too Cheap for Investors To Ignore?
The consumer staples sector is beaten down and offering a significant value and high yield for long-term-minded investors 
Via MarketBeat
Topics Bonds Cannabis Economy
Exposures Cannabis Debt Markets Interest Rates
Medifast: Transforming Lives And Reshaping The Health & Wellness Industry
By Ernest Dela Aglanu, Benzinga 
Via TheNewswire.com
Astaxanthin Market Expected to Exceed $1.2 Billion By 2026 Leading the Nutraceutical Segment for Lucrative Growth
Via FinancialNewsMedia
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.